Research News: Continuation of Immunotherapy

Posted by cancerconnect @cancerconnect, Apr 11, 2017

Some Head and Neck Cancer Patients Benefit From Continued Checkpoint Inhibitor Treatment After Tumor Growth, read more here: http://news.cancerconnect.com/head-neck-cancer-patients-benefit-continued-checkpoint-inhibitor-treatment-tumor-growth/

Interested in more discussions like this? Go to the Head and Neck Cancers group.

Please sign in or register to post a reply.

version 3.3.6.2.8.8
Page loaded in 0.067 seconds